Chembio Diagnostics (CEMI, $5.46) was one of the top gainers this week, climbing +43.31% to $5.46 per share. Tickeron A.I.dvisor analyzed 204 stocks in the Medical Specialties Industry over the last week and discovered that 131 of them (64.44%) trended up while 73 of them (35.56%) trended down. Tickeron A.I.dvisor found 238 similar cases when CEMI's price jumped over 5% within one week. In 134 out of those 238 cases, CEMI's price went up during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend continuation for CEMI are 56%.
The Moving Average Convergence Divergence (MACD) just turned positive. Considering data from situations where CEMI's MACD histogram became positive, Tickeron AI shows that in 30 of 42 cases, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The Moving Average Convergence Divergence (MACD) just turned positive. Considering data from situations where CEMI's MACD histogram became positive, Tickeron AI shows that in 30 of 42 cases, the price rose further within the following month. The odds of a continued Uptrend are 71%.